GI
BRLI

GAMCO Investors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

GAMCO Investors’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-62,600
Closed -$2.58M – 859
2015
Q2 		$2.58M Sell
62,600
-2,400
-4% -$86K 0.01% 491
2015
Q1 		$2.29M Buy
65,000
+6,000
+10% +$203K 0.01% 516
2014
Q4 		$1.9M Buy
59,000
+1,000
+2% +$28.9K 0.01% 541
2014
Q3 		$1.63M Sell
58,000
-500
-0.9% -$15.2K 0.01% 577
2014
Q2 		$1.77M Sell
58,500
-200
-0.3% -$5.52K 0.01% 560
2014
Q1 		$1.63M Buy
58,700
+2,300
+4% +$60.2K 0.01% 553
2013
Q4 		$1.44M Buy
56,400
+700
+1% +$21.6K 0.01% 569
2013
Q3 		$1.66M Buy
55,700
+1,500
+3% +$41.7K 0.01% 541
2013
Q2 		$1.56M Buy
+54,200
New +$1.49M 0.01% 526

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

GAMCO Investors's BRLI Position: Q3 2015 in Review

GAMCO Investors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 62,600 shares — an estimated $2.58M sold.

GAMCO Investors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $2.58M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • GAMCO Investors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • GAMCO Investors sold 62,600 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.58M.
  • GAMCO Investors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • GAMCO Investors's BIO-REFERENCE LABS INC-NEW- position peaked at $2.58M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on GAMCO Investors's 13F filing for Q3 2015, filed 23 Oct 2015.